The estimated Net Worth of Ian T Meredith is at least $2.92 millió dollars as of 28 March 2022. Ian Meredith owns over 6,588 units of Boston Scientific stock worth over $2,329,121 and over the last 8 years he sold BSX stock worth over $591,012. In addition, he makes $0 as Executive Vice President és Global Chief Medical Officer at Boston Scientific.
Ian has made over 24 trades of the Boston Scientific stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 6,588 units of BSX stock worth $287,764 on 28 March 2022.
The largest trade he's ever made was selling 7,018 units of Boston Scientific stock on 28 December 2021 worth over $303,248. On average, Ian trades about 1,773 units every 45 days since 2017. As of 28 March 2022 he still owns at least 28,082 units of Boston Scientific stock.
You can see the complete history of Ian Meredith stock trades at the bottom of the page.
Prof. Ian T. Meredith AM serves as Executive Vice President, Global Chief Medical Officer of the Company. In this role, he is responsible for leading clinical science and medical affairs across Boston Scientific and providing global leadership of the company's clinical trial strategy. Prior to joining Boston Scientific, Professor Meredith served as professor and director of MonashHeart, and executive director of the Monash Cardiovascular Research Centre at Monash University in Melbourne, Australia, from September 2005 to December 2016. Professor Meredith has over 25 years of experience as a clinical and interventional cardiologist and also served as director of the Cardiac Catheterization Laboratories and Interventional Cardiology. Professor Meredith has been a member of the Board of the National Heart Foundation (Australia) and a member of the Cardiac Society of Australia and New Zealand National Board. Professor Meredith received a Ph.D. from the Baker Institute in Melbourne and an Order of Australia (AM) in the General Division for service to medicine in the field of Cardiology as a clinician and researcher.
Ian Meredith is 63, he's been the Executive Vice President és Global Chief Medical Officer of Boston Scientific since 2017. There are 4 older and 24 younger executives at Boston Scientific. The oldest executive at Boston Scientific Corp. is Yoshiaki Fujimori, 69, who is the Independent Director.
Ian's mailing address filed with the SEC is 300 BOSTON SCIENTIFIC WAY, , MARLBOROUGH, MA, 01752-1234.
Over the last 20 years, insiders at Boston Scientific have traded over $938,841,783 worth of Boston Scientific stock and bought 1,398,972 units worth $16,231,539 . The most active insiders traders include Peter M Nicholas, John E Abele és Michael F Mahoney. On average, Boston Scientific executives and independent directors trade stock every 3 days with the average trade being worth of $4,899,929. The most recent stock trade was executed by Michael F Mahoney on 5 September 2024, trading 162,777 units of BSX stock currently worth $13,212,609.
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.
Boston Scientific executives and other stock owners filed with the SEC include: